Indefinite Delivery Contract SPE2DX15D3508

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 single-award IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has no set-aside designation, indicating open competition. Under this IDC, Amerisourcebergen has received numerous firm fixed-price delivery orders from the DLA, valued between $300 and $18,988, for the provision of TRICARE West medical supplies and pharmaceuticals to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

In addition to the DLA IDC, Amerisourcebergen also holds a separate $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracting mechanisms enable the efficient procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The awarded delivery orders demonstrate Amerisourcebergen's critical role as a key vendor for federal healthcare programs, leveraging its extensive supply chain network and expertise in pharmaceutical distribution.